China to fuel bigger pharma growth in 2011
Drug market of China is projected to grow 25 percent to 27 percent to more than $50 billion, to become the world's third-largest pharma market.
Next year is shaping up to be slightly better for global pharma growth. But once again, it's emerging markets leading the charge. According to IMS Health's annual forecast, double-digit expansion in developing countries next year will make up for less-exciting growth in the U.S. and Europe.
Think five to seven percent global growth, with 15 to 17 percent expansion in 17 emerging markets, but only one to three percent in Europe, where pricing pressure is reining in revenues. The U.S. pharma market is expected to grow three to five percent. Totals? $890 billion in worldwide pharma sales; $320 billion to $330 billion in the U.S.
But it's China that's really raring to go. That drug market there is projected to grow 25 percent to 27 percent to more than $50 billion, to become the world's third-largest pharma market.
"[T]he underlying constraints to growth in developed markets are stronger than ever--including the impact of major patent expirations and payer me
Related News
-
News Strategies for managing an outsourcing partner
Robust oversight linked to increased efficiency and better communication with outsourcing partners. -
News Updated: CPHI North America 2022 Blog
Follow along for live updates from CPHI North America, taking place in Philadelphia, PA from May 17-19. -
News Greater standardisation needed for effective ESG reporting - Expert panel
Increased transparency and standardisation in ESG reporting frameworks is emerging as a key requirement for investors. -
News MedPharm: Increased investment driving developments in topical drugs market
We caught up with MedPharm at CPHI North America to discuss opportunities in the topical and transdermal products space. -
News Pharmapack Awards 2022: Winners Revealed
The jury assessed a wide range of industry-changing innovations in packaging and drug delivery, ultimately selecting seven winners. -
News What it means to be 'At the heart of Pharma'
Informa Markets colleagues explain the motivations behind CPHI’s rebrand. -
News CPhI Podcast Series: Leveraging data science for sustainable autoinjector development
Environmental impact is an area of increasing focus for the pharma and biopharma industries, with companies like Merck, Pfizer and GlaxoSmithKline setting ambitious targets for carbon neutrality and laying plans for waste reduction. -
News Thermo Fisher and Charles River join consortium using robotics to produce cell therapies at scale
The Consortium aims to increase the scale of cell therapy manufacturing to a level impossible with current manual processes.
Position your company at the heart of the global Pharma industry with a CPhI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPhI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance